Pharmafile Logo
Pharmafocus logo
Advanced Search

Research and Development

Showing 15 posts of 9573 posts found.

screen_shot_2012-06-06_at_10

William Kaelin Jr elected to Lilly board

June 6, 2012 Business Services, Manufacturing and Production, Research and Development, Sales and Marketing Cancer, Kaelin, lilly

Eli Lilly has elected William Kaelin Jr to its board of directors. Dr Kaelin, 54, is a Professor in the Department of …
Appointment

Merck Serono staff may strike over Geneva HQ closure

June 6, 2012 Manufacturing and Production, Research and Development ASCO, Basel, Geneva, Merck Serono, Novartis, R&D

Workers at Merck Serono’s Swiss headquarters in Geneva have threatened industrial action over the company’s plans to shut down the …
News
ASCO

Herceptin successor impresses at ASCO

June 6, 2012 Research and Development, Sales and Marketing ASCO, Cancer, EMILIA, FDA, Roche, T-DM1

Roche’s new ‘smart bomb’ breast cancer drug T-DM1 has impressed at this year’s ASCO conference in Chicago. The trial showed it …
News
Bristol-Myers Squibb

BMS establishes cancer vaccine network

June 1, 2012 Research and Development, Sales and Marketing

Bristol-Myers Squibb has formed a network of ten institutions to advance work on using the body’s own immune system to …
News

ROCK medical communications appoints two new account managers

June 1, 2012 Medical Communications, Research and Development, Sales and Marketing ROCK, medical communications, pharma appointment

ROCK medical communications has appointed two new team members: Suzanne Smith and Nicola Wood. Suzanne joins from Chameleon Communications, where …
Appointment

Boehringer appoints new executive director of Consumer Healthcare Marketing

May 31, 2012 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Boehringer Ingelheim

Boehringer Ingelheim has announced the appointment of Ross Ullman as the executive director marketing of the Consumer Healthcare division.  In …
Appointment

Pharma relieved as Senate backs FDA fees

May 30, 2012 Business Services, Manufacturing and Production, Research and Development, Sales and Marketing FDA, PDUFA, PhRMA, US

The US Senate has approved a law that will continue to allow pharma firms to help fund the FDA.  The …
News

Photo story: GSK’s 2012 legacy

May 30, 2012 Research and Development Andrew Witty, GSK, Olympics 2012

Tuesday May 29, 2012: GlaxoSmithKline chief executive, Sir Andrew Witty makes a speech at a conference at the company’s headquarters …
Feature

GSK starts combination trial for melanoma

May 30, 2012 Research and Development, Sales and Marketing GSK, R&D, Roche, Zelboraf, melanoma

GlaxoSmithKline has begun a combination trial for two of its investigational skin cancer drugs.  The firm will combine dabrafenib, its …
News

UK Prix Galien shortlist announced

May 30, 2012 Business Services, Medical Communications, Research and Development, Sales and Marketing Bayer, Janssen, Xarelto, awards, prix galien

The UK award for the most innovative new drug has been moved a step closer with the release of a …
News
brian_jolly_at_onyx_scientific_

Onyx appoints Brian Jolly to commercial team

May 30, 2012 Business Services, Manufacturing and Production, Research and Development, Sales and Marketing CMO, Onyx, manufacturing

Onyx Scientific the chemistry and manufacturing specialist has bolstered its business development team with the appointment of a new director. …
Appointment

Sanofi/Regeneron cholesterol drug reaches Phase III

May 29, 2012 Research and Development, Sales and Marketing Amgen, PCKS9, Regeneron, SAR236553, Sanofi

Sanofi and Regeneron’s anti-cholesterol drug has impressed in a mid-stage trial, and will now progress into Phase III.  The firms’ …
News

Lundbeck’s Alzheimer’s drug shows promise

May 29, 2012 Research and Development, Sales and Marketing Alzheimer's, Lundbeck

Lundbeck’s Alzheimer’s candidate Lu AE58054 has shown signs in a phase II study of helping patients’ mental activity. Sufferers receiving …
News
Pradaxa image

European OK for Pradaxa, but more details required

May 29, 2012 Research and Development, Sales and Marketing Boehringer, CHMP, EMA, Europe, Pradaxa

The European Medicines Agency says that Boehringher’s Pradaxa can stay on the market, but will need more safety information.  The …
News

Life bolsters its client services team with two additions

May 28, 2012 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing

Life Healthcare Communications has developed its client services team with two new appointments to further support the needs of its …
Appointment
The Gateway to Local Adoption Series

Latest content

STADA and Bio-Thera’s Gotenfia receives positive CHMP opinion for autoimmune diseases

December 18, 2025

Norgine enters exclusive licensing agreement with Vir Biotechnology

December 18, 2025

Incyclix appoints Kimberly Blackwell to Board of Directors

December 17, 2025

Hansa Biopharma appoints Max Sakajja as Vice President, General Manager Europe and International

December 17, 2025

GSK’s Exdensur receives MHRA approval for asthma and rhinosinusitis

December 16, 2025